PL366027A1 - Wydajny sposób wytwarzania inhibitora czynnika Xa - Google Patents

Wydajny sposób wytwarzania inhibitora czynnika Xa

Info

Publication number
PL366027A1
PL366027A1 PL01366027A PL36602701A PL366027A1 PL 366027 A1 PL366027 A1 PL 366027A1 PL 01366027 A PL01366027 A PL 01366027A PL 36602701 A PL36602701 A PL 36602701A PL 366027 A1 PL366027 A1 PL 366027A1
Authority
PL
Poland
Prior art keywords
inhibitor
factor
preparation
efficient process
efficient
Prior art date
Application number
PL01366027A
Other languages
English (en)
Inventor
Luigi Anzalone
Fuqiang Jin
David J. Meloni
Jung-Hui Sun
Christopher A. Teleha
Jia Cheng Zhou
Thomas E. Smyser
Hui-Yin Li
Original Assignee
Bristol-Myers Squibb Pharma Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Pharma Company filed Critical Bristol-Myers Squibb Pharma Company
Publication of PL366027A1 publication Critical patent/PL366027A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL01366027A 2000-09-22 2001-09-12 Wydajny sposób wytwarzania inhibitora czynnika Xa PL366027A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23462200P 2000-09-22 2000-09-22
PCT/US2001/028406 WO2002024690A2 (en) 2000-09-22 2001-09-12 Efficient process for the preparation of a factor xa inhibitor

Publications (1)

Publication Number Publication Date
PL366027A1 true PL366027A1 (pl) 2005-01-24

Family

ID=22882119

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01366027A PL366027A1 (pl) 2000-09-22 2001-09-12 Wydajny sposób wytwarzania inhibitora czynnika Xa

Country Status (23)

Country Link
US (3) US6667332B2 (pl)
EP (1) EP1366045A2 (pl)
JP (1) JP2004529853A (pl)
KR (1) KR20040043089A (pl)
CN (1) CN1610679A (pl)
AU (1) AU2001292612A1 (pl)
BG (1) BG107813A (pl)
BR (1) BR0114102A (pl)
CA (1) CA2424576A1 (pl)
CZ (1) CZ2003835A3 (pl)
EE (1) EE200300116A (pl)
HR (1) HRP20030316A2 (pl)
HU (1) HUP0500133A2 (pl)
IL (1) IL155043A0 (pl)
IS (1) IS6754A (pl)
MX (1) MXPA03002493A (pl)
NO (1) NO20031308L (pl)
PL (1) PL366027A1 (pl)
RU (1) RU2003111464A (pl)
SK (1) SK4892003A3 (pl)
TW (1) TW593314B (pl)
WO (1) WO2002024690A2 (pl)
ZA (1) ZA200302971B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339099B1 (en) * 1997-06-20 2002-01-15 Dupont Pharmaceuticals Company Guanidine mimics as factor Xa inhibitors
JP2004504295A (ja) * 2000-07-18 2004-02-12 ボーン ケア インターナショナル インコーポレイテッド 安定化1α−ヒドロキシビタミンD
TW200302225A (en) * 2001-12-04 2003-08-01 Bristol Myers Squibb Co Substituted amino methyl factor Xa inhibitors
US20040067995A1 (en) 2002-10-02 2004-04-08 Wong Pancras C. Novel combination of a factor Xa inhibitor and clopidogrel
US7368846B2 (en) 2002-11-06 2008-05-06 Matsushita Electric Industrial Co., Ltd. Microactuator with displacement sensing function and deformable mirror including the microactuator
US7429581B2 (en) * 2002-12-23 2008-09-30 Sanofi-Aventis Deutschland Gmbh Pyrazole-derivatives as factor Xa inhibitors
US20050059719A1 (en) * 2003-09-16 2005-03-17 Badawy Sherif Ibrahim Farag Solid dosage formulation containing a Factor Xa inhibitor and method
HRP20221373T1 (hr) 2014-03-07 2023-01-06 Biocryst Pharmaceuticals, Inc. Supstituirani pirazoli kao inhibitori kalikreina u ljudskoj plazmi
CN119626346B (zh) * 2025-02-14 2025-05-06 四川省肿瘤医院 一种医学基因测序数据的模式识别方法及设备

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020357A (en) * 1996-12-23 2000-02-01 Dupont Pharmaceuticals Company Nitrogen containing heteroaromatics as factor Xa inhibitors
ZA985247B (en) * 1997-06-19 1999-12-17 Du Pont Merck Pharma Guanidine mimics as factor Xa inhibitors.
US6339099B1 (en) * 1997-06-20 2002-01-15 Dupont Pharmaceuticals Company Guanidine mimics as factor Xa inhibitors

Also Published As

Publication number Publication date
US20020061917A1 (en) 2002-05-23
RU2003111464A (ru) 2004-10-27
MXPA03002493A (es) 2004-09-10
US6747158B2 (en) 2004-06-08
AU2001292612A1 (en) 2002-04-02
CA2424576A1 (en) 2002-03-28
SK4892003A3 (en) 2004-04-06
US20040198787A1 (en) 2004-10-07
BR0114102A (pt) 2005-04-19
CN1610679A (zh) 2005-04-27
CZ2003835A3 (cs) 2003-12-17
US6667332B2 (en) 2003-12-23
NO20031308L (no) 2003-05-07
TW593314B (en) 2004-06-21
HRP20030316A2 (en) 2005-02-28
WO2002024690A8 (en) 2002-08-08
WO2002024690A3 (en) 2003-09-25
BG107813A (bg) 2004-01-30
NO20031308D0 (no) 2003-03-21
HUP0500133A2 (hu) 2005-04-28
KR20040043089A (ko) 2004-05-22
EP1366045A2 (en) 2003-12-03
US20030212117A1 (en) 2003-11-13
IL155043A0 (en) 2003-10-31
ZA200302971B (en) 2005-05-09
JP2004529853A (ja) 2004-09-30
WO2002024690A2 (en) 2002-03-28
IS6754A (is) 2003-03-21
EE200300116A (et) 2005-04-15

Similar Documents

Publication Publication Date Title
AU2001273040A1 (en) Factor xa inhibitors
PT1330370E (pt) Processo para o fabrico de elementos de superfície
HUP0402027A3 (en) Process for the preparation of a xantophyll
GB0025221D0 (en) New process
HUP0000283A3 (en) New process for the production of quetiapine
HRP20040161A2 (en) Process for the preparation of a 14-hydroxynormorphinone derivative
SG99351A1 (en) Process for the manufacture of a crystalline solid
IL155043A0 (en) Efficient process for preparation of a factor xa inhibitor
PL350941A1 (en) Pyrazole-3-on-derivative as factor xa inhibitors
GB0031094D0 (en) New Process
GB0014546D0 (en) A novel process
GB0107062D0 (en) A mortar table
GB0108016D0 (en) Process for the preparation of a catalyst
HK1057372A (en) Efficient process for the preparation of a factor xa inhibitor
PT1296928E (pt) Um processo para a purificação de diacereína
PL358006A1 (pl) Nowy sposób sprzęgania
AU744296C (en) A process for the reduction of pterins
GB0108017D0 (en) Process for the preparation of a catalyst
IL155189A0 (en) NOVEL CRYSTALLINE FORMS OF A FACTOR Xa INHIBITOR
GB0025940D0 (en) Solvogels & a method of manufacturing the same
GB0012448D0 (en) New process
AU141604S (en) A set of partition jointers
GB0105911D0 (en) Process for making a thrombon inhibitor
GB0003396D0 (en) A set of parts
GB0010572D0 (en) A set of parts

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)